10/20/2025 / By Willow Tohi
For nearly 30 years, pediatricians across the U.S. and Europe followed a dangerous recommendation: delay peanut introduction until age three—especially for infants with a family history of allergies. This policy, endorsed by the American Academy of Pediatrics (AAP), was based on the flawed assumption that early exposure would “sensitize” children, triggering lifelong allergies. Instead, the opposite happened—peanut allergies skyrocketed, particularly in countries like the U.K., where avoidance was strictly enforced. By the early 2000s, peanut allergies had tripled, affecting 1 in 50 children, with severe reactions leading to anaphylaxis, ER visits and even deaths.
Then, in 2015, the groundbreaking Learning Early About Peanut Allergy (LEAP) trial shattered this dogma. The study, published in The New England Journal of Medicine, proved that early peanut introduction—not avoidance—was the key to prevention. The findings were so compelling that they forced an overnight reversal of medical guidelines. Now, nearly a decade later, a new real-world study from Children’s Hospital of Philadelphia (CHOP) confirms that these updated guidelines have prevented tens of thousands of peanut allergy cases—a major victory for public health.
The LEAP trial was a landmark study involving 640 high-risk infants (those with severe eczema or egg allergies). Researchers divided the infants into two groups:
The results were stunning:
Even more remarkable? The protection lasted. A follow-up study (LEAP-On) found that 70 percent of children who consumed peanuts early remained allergy-free into adolescence, even after stopping peanut consumption for a year.
Despite overwhelming evidence, adoption of early peanut introduction was painfully slow. A 2023 survey revealed that only 29 percent of pediatricians followed the 2017 guidelines, which expanded recommendations to all infants—not just high-risk ones. Many doctors feared unintended reactions outside clinical trials, while parents were confused by vague advice (“How much peanut? What form?”).
But the 2024 CHOP study, analyzing 125,000+ children, removed all doubt: Early peanut introduction works in the real world. The data showed a 16 percent drop in peanut allergy rates since guidelines shifted—proving that policy changes save lives.
The 2021 NIH/NIAID guidelines provide clear, actionable steps:
While peanut allergies are declining, overall food allergies are still rising—milk, eggs and tree nuts remain major concerns. Experts warn that education gaps and food insecurity hinder progress, especially in low-income communities where allergen-free diets are often mistakenly promoted.
This isn’t just about peanuts—it’s about reshaping how we approach immune health. Science is proving that early exposure trains the immune system to recognize food as food, not a threat.
Decades of misguided medical advice created an allergy epidemic—but science has corrected course. The lesson? Early exposure prevents disease. And now, the data proves it beyond doubt.
Next Steps:
The era of fear-based feeding is over. The future? Prevention through science.
Sources for this article include:
Tagged Under:
alternative medicine, Censored Science, children's health, early exposure, food allergy, health science, immune system, natural cures, natural health, Naturopathy, peanuts, prevention, progress, Public Health, real investigations, remedies, research
This article may contain statements that reflect the opinion of the author
COPYRIGHT © 2017 REAL SCIENCE NEWS